Lu‐Gang Yu
- Molecular Biology top 5%
- Immunology top 1%
- Oncology top 5%
- Organic Chemistry top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Co-authors
- Jonathan M. RhodesAnna U. NewlaczylXiuli GuoQicheng ZhaoHannah BarrowJ.D. MiltonJohn HilkensDavid G. Fernig
- Topics
- Galectins and Cancer Biology (47 papers)Glycosylation and Glycoproteins Research (37 papers)Signaling Pathways in Disease (13 papers)
- Cited by
- ImmunologyMolecular BiologyOncology
- Partner nations
- United KingdomChinaNetherlands
In The Last Decade
Lu‐Gang Yu
97 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 159
- Molecular Biology 2.5k
- Immunology 2.0k
- Oncology 616
- Organic Chemistry 292
- Radiology, Nuclear Medicine and Imaging 287
Countries citing papers authored by Lu‐Gang Yu
This map shows the geographic impact of Lu‐Gang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu‐Gang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu‐Gang Yu more than expected).
Fields of papers citing papers by Lu‐Gang Yu
This network shows the impact of papers produced by Lu‐Gang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu‐Gang Yu. The network helps show where Lu‐Gang Yu may publish in the future.
Co-authorship network of co-authors of Lu‐Gang Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Lu‐Gang Yu. A scholar is included among the top collaborators of Lu‐Gang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu‐Gang Yu. Lu‐Gang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 13 | |
| 4 | 10 | |
| 5 | 16 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 87 | |
| 10 | Effects of isorhapontigenin on cell cycle arrest and down-regulation of cyclin D1 expression in bladder cancer cells | 1 |
| 11 | 12 | |
| 12 | 139 | |
| 13 | 138 | |
| 14 | Clinical Study on Parkinson's Disease Treated with "Xifeng Zhichan Decoction" and Madopar | 1 |
| 15 | 248 | |
| 16 | 62 | |
| 17 | 25 | |
| 18 | 67 | |
| 19 | 99 | |
| 20 | 54 |
About Lu‐Gang Yu
Lu‐Gang Yu is a scholar working on Immunology, Molecular Biology and Oncology, having authored 102 papers that have together received 3.7k indexed citations. Recurring topics across this work include Galectins and Cancer Biology (47 papers), Glycosylation and Glycoproteins Research (37 papers) and Signaling Pathways in Disease (13 papers). The work is most often cited by research in Immunology (2.0k citations), Molecular Biology (2.5k citations) and Oncology (616 citations). Lu‐Gang Yu has collaborated with scholars based in United Kingdom, China and Netherlands. Frequent co-authors include Jonathan M. Rhodes, Anna U. Newlaczyl, Xiuli Guo, Qicheng Zhao, Hannah Barrow, J.D. Milton, John Hilkens, David G. Fernig, Barry J. Campbell and D. Mark Pritchard. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.